MinorSecond-generation antihistamine×Non-steroidal anti-inflammatory drugs (NSAIDs)
Updated · Methodology
Mechanism
Fexofenadine is barely metabolised, in the liver or elsewhere. It is eliminated mainly in bile, with up to 10% of the dose excreted unchanged in urine, and its half-life is 11–15 hours (fexofenadine SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 5.2). Its exposure is changed by P-gp inhibitors or inducers such as erythromycin and ketoconazole (fexofenadine SmPC, AEMPS, section 4.5). Ibuprofen is extensively metabolised in the liver by hydroxylation and carboxylation, and about 90% is excreted in the urine as inactive metabolites, mainly glucuronides (ibuprofen SmPC, AEMPS, section 5.2). Ibuprofen is not among the P-gp modulators named in the fexofenadine SmPC, and fexofenadine does not interact through hepatic mechanisms (fexofenadine SmPC, AEMPS, section 4.5).
Symptoms
The documents describe no symptoms caused by this combination. Common adverse effects of fexofenadine are headache, somnolence, dizziness and nausea (fexofenadine SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.8). Like other non-steroidal anti-inflammatory drugs, ibuprofen can cause gastrointestinal bleeding, ulceration and perforation (ibuprofen SmPC, AEMPS, section 4.4).
Management
According to the documents, the combination is acceptable and no dose change of ibuprofen or fexofenadine is needed. Neither document names the pair, and the drugs are eliminated by different routes (ibuprofen and fexofenadine SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS, sections 4.5 and 5.2). Fexofenadine is used with caution in older people and in renal or hepatic impairment because data are limited (fexofenadine SmPC, AEMPS, section 4.4). Ibuprofen is taken at the lowest effective dose for the shortest possible time (ibuprofen SmPC, AEMPS, sections 4.2 and 4.4).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- AEMPS: Ficha técnica: Ibuprofeno (nº registro 63597), secciones 4.2, 4.4 y 4.5 (2025)– AEMPS, CIMA, nº registro 63597, revisión 04/2025, secciones 4.2, 4.4 y 4.5
- AEMPS: Ficha técnica: Fexofenadina, Fexofenadina Opella 180 mg (nº registro 61911), sección 4.5 (2026)– AEMPS, CIMA, nº registro 61911 (Fexofenadina Opella 180 mg comprimidos recubiertos con película, Opella Healthcare Spain), revisión 04/2026, secciones 4.4, 4.5, 4.7, 4.8, 5.1 y 5.2